The AD/PD™ series of conferences have always been notable for an excellent program that balances cutting-edge scientific research and advanced clinical discussions. AD/PD™ 2023 will continue that tradition with sessions of Forum Discussions, Symposia, Oral and Poster Presentations devoted to latest breakthroughs in treatment, translational R&D, early diagnosis, drug development and clinical trials in Alzheimer’s, Parkinson’s and other related neurological disorders.

Please note the program is preliminary and is subject to change. By clicking on the Interactive Program button, you can also view the 1,100 Poster Abstracts.